Korean Circ J.  2008 Dec;38(12):659-665. 10.4070/kcj.2008.38.12.659.

Technical Feasibility and Early Clinical Outcomes Associated With Distal Filter Device Use for All Carotid Stenting Procedures

Affiliations
  • 1Division of Cardiology, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea. myheart@cnu.ac.kr
  • 2Department of Neurology, Chungnam National University School of Medicine, Daejeon, Korea.
  • 3Department of Surgery, Chungnam National University School of Medicine, Daejeon, Korea.

Abstract

BACKGROUND AND OBJECTIVES
Distal filter devices (DFDs) are known to reduce the occurrence of embolic events by capturing embolic debris and thereby preventing intracranial embolization during carotid artery stenting (CAS). However, there are few reports addressing DFD use in CAS procedures. Therefore, we evaluated the technical feasibility and clinical outcomes associated with DFD use in all CAS procedures. SUBJECTS AND METHODS: Between June 2004 and June 2008, all CAS procedures performed at our center were completed with DFD protection. We recorded periprocedural data and watched for new neurologic abnormalities for 24 hours after the procedure. One-month clinical outcomes were also evaluated. RESULTS: A total of 100 carotid lesions in 94 patients (age 68+/-8 years; 79 men) were treated with percutaneous stenting using DFDs (FilterWire EZ(TM), Boston Scientific Co, US). DFD application was successful in all procedures. Periprocedural strokes occurred in five procedures (one major, one minor, and three transient ischemic attacks). The one-month rates of stroke and death were 6% and 2%, respectively. Difficult filter placement occurred in two procedures due to tight stenosis and severe common carotid artery (CCA)-to-internal carotid artery (ICA) angulation. Difficult stent delivery occurred in three instances: one due to severe lesion calcification and two due to proximal tortuosity. The retriever failed to acquire the filter in nine procedures. Four of nine retrieval difficulties were related to severe CCA-ICA angulation. CONCLUSION: DFD use was successful in all CAS procedures, was relatively safe, and had few periprocedural complications.

Keyword

Protective devices; Stents; Carotid arteries

MeSH Terms

Boston
Carotid Arteries
Carotid Artery, Common
Constriction, Pathologic
Dapsone
Humans
Protective Devices
Stents
Stroke
Dapsone

Cited by  1 articles

Carotid Artery Stenting
Jae-Hyeong Park, Jae-Hwan Lee
Korean Circ J. 2018;48(2):97-113.    doi: 10.4070/kcj.2017.0208.


Reference

1. Wholey MH, Wholey M, Mathias K, et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv. 2000. 50:160–167.
2. Roubin GS, New G, Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation. 2001. 103:532–537.
3. Mathur A, Roubin GS, Iyer SS, et al. Predictors of stroke complicating carotid artery stenting. Circulation. 1998. 97:1239–1245.
4. Reimers B, Corvaja N, Moshiri S, et al. Cerebral protection with filter devices during carotid artery stenting. Circulation. 2001. 104:12–15.
5. Thomas DJ. Protected carotid artery stenting versus endarterectomy in high-risk patients reflections from SAPPHIRE. Stroke. 2005. 36:912–913.
6. Ohki T, Veith FJ. Critical analysis of distal protection devices. Semin Vasc Surg. 2003. 16:317–325.
7. Ko YG, Park S, Kim JY, et al. Carotid artery stenting with distal protection device: early experience. Korean Circ J. 2005. 35:61–68.
8. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991. 325:445–453.
9. Wityk RJ, Pessin MS, Kaplan RF, Caplan LR. Serial assessment of acute stroke using the NIH Stroke Scale. Stroke. 1994. 25:362–365.
10. Zahn R, Ischinger T, Mark B, et al. Embolic protection devices for carotid artery stenting: is there a difference between filter and distal occlusive devices? J Am Coll Cardiol. 2005. 45:1769–1774.
11. Cremonesi A, Manetti R, Setacci F, Setacci C, Castriota F. Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke. 2003. 34:1936–1941.
12. Kastrup A, Groschel K, Krapf H, Brehm BR, Dichgans J, Schulz JB. Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature. Stroke. 2003. 34:813–819.
13. Whitlow PL, Lylyk P, Londero H, et al. Carotid artery stenting protected with an emboli containment system. Stroke. 2002. 33:1308–1314.
14. Shaw JA, Menard M, Eisenhauer AC. Approaches to difficult filter retrieval in carotid stenting. Catheter Cardiovasc Interv. 2005. 64:18–22.
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr